Pirisi M
-
Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
-
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases.
-
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.
-
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases.